ライフサイエンスコーパス: posterior capsule opacification

1 nt, cystoid macular oedema, glare, halos and posterior capsule opacification.

2 an effective capsular bend as a deterrent to posterior capsule opacification.

3 ng mechanism for the aberrant cell growth in posterior capsule opacification.

4 , cystoid macular oedema (CMO), cataract and posterior capsule opacification.

5 pressure spikes, cystoid macular edema, and posterior capsule opacification.

6 and could be important in the development of posterior capsule opacification.

7 practical for use in longitudinal studies of posterior capsule opacification.

8 mmunotoxin may be effective in prevention of posterior capsule opacification.

9 d Pande et al. for precise quantification of posterior-capsule opacification.

10 tion (between piggyback intraocular lenses), posterior capsule opacification and lens epithelial cell

11 and pharmacologic methods); 2) treatment of posterior capsule opacification; and 3) characteristics

12 how resistant an intraocular lens will be to posterior capsule opacification as a consequence of rege

13 ept that sharp optic edges markedly decrease posterior capsule opacification as compared with round-e

14 Posterior-capsule opacification, by far the most common

15 Posterior capsule opacification developed in 11 eyes (57

16 Posterior capsule opacification developed in 14 eyes (34

17 Evaluation of Posterior Capsule Opacification (EPCO) image analysis so

18 d with retroillumination using evaluation of posterior capsule opacification (EPCO) software.

19 ecial interest are techniques for inhibiting posterior capsule opacification in pediatric patients by

20 d strength, which may decrease resistance to posterior capsule opacification in the face of a regener

21 sterior capsulorhexis is required to inhibit posterior-capsule opacification in pediatric patients; w

22 Posterior capsule opacification is a frequent postoperat

23 Posterior capsule opacification is also potentially solv

24 Posterior capsule opacification is an ongoing cellular r

25 Posterior capsule opacification is the most frequent lat

26 Posterior capsule opacification occurred in 66 eyes (82.

27 ll changes in the percentage area covered by posterior capsule opacification over time.

28 To objectively assess the long-term posterior capsule opacification (PCO) and neodymium-dope

29 Posterior capsule opacification (PCO) arises because of

30 provements in intraocular lens (IOL) design, posterior capsule opacification (PCO) arising from lens

31 The fibrotic lens disorder posterior capsule opacification (PCO) develops in millio

32 This resilient growth gives rise to posterior capsule opacification (PCO) in a significant p

33 Posterior capsule opacification (PCO) is a complication

34 Posterior capsule opacification (PCO) is the most common

35 Posterior capsule opacification (PCO) is the most common

36 ct surgery is common, routine and effective, posterior capsule opacification (PCO) occurs in 30-50% o

37 tients gradually develop the complication of posterior capsule opacification (PCO) or secondary catar

38 dy were to determine the 5-year incidence of posterior capsule opacification (PCO) requiring Nd:YAG l

39 utive pseudophakic patients with symptomatic posterior capsule opacification (PCO) underwent Nd:YAG l

40 ts due to a wound-healing response, known as posterior capsule opacification (PCO), following catarac

41 s lenticular migration, thus contributing to posterior capsule opacification (PCO).

42 anti-TGF-beta2 antibody in a rodent model of posterior capsule opacification (PCO).

43 ptic edge using an in vitro culture model of posterior capsule opacification (PCO).

44 srupting complication of cataract surgery is posterior capsule opacification (PCO; secondary cataract

45 the eye this can cause blindness because of posterior capsule opacification, proliferative vitroreti

46 ion, allowing for a more rapid assessment of posterior capsule opacification resistance.

47 ge design appreciably improves resistance to posterior capsule opacification, significant factors rem

48 med and analyzed for PCO using Evaluation of Posterior Capsule Opacification software.

49 This review addresses 1) inhibition of posterior capsule opacification (surgical techniques, in

50 active lens exchange suggest higher rates of posterior capsule opacification than with standard catar

51 th and angle width in pseudophakic eyes with posterior capsule opacification were measured with anter